Skip to main content
. 2015 Nov 12;10(11):e0142904. doi: 10.1371/journal.pone.0142904

Fig 2. Muscle-enriched and vascular-enriched miRNAs are not elevated in PF compared with serum.

Fig 2

(A) Expression levels of miR-133a in serum and PF, (B) Expression levels of miR-133a in the serum of patients with aortic stenosis (AS), stable angina pectoris (sAP) and unstable angina pectoris (uAP), (C) Expression levels of miR-92a in serum and PF, (D) Expression levels of miR-92a in serum of patients with AS, sAP and uAP, (E) Expression levels of miR-126 in serum and PF, (F) Expression levels of miR-126 in the serum of patients with AS, sAP and uAP. Each miRNA level was normalized using exogenous cel-miR-39. Data are presented as median and interquartile range. *P<0.05. **P<0.01. (G) Expression levels of miR-423-5p in cardiomyocytes and fibroblasts from neonatal mice hearts, n = 4. miR-423-5p was normalized using U6. Data are presented as mean ± SEM. * p<0.05